기사 (249건) 리스트형 웹진형 타일형 “Xpovio, the only hope for patients with multiple myeloma who have exhausted all treatments” “Xpovio, the only hope for patients with multiple myeloma who have exhausted all treatments” Market cap of KOSPI pharmaceutical index dropped by KRW 2.4481 trillion in January Market cap of KOSPI pharmaceutical index dropped by KRW 2.4481 trillion in January LucentisㆍVenclexta benefits cut by 30% and 12.2%, Vfend increases by 19.5% LucentisㆍVenclexta benefits cut by 30% and 12.2%, Vfend increases by 19.5% Atopic dermatitis treatment Dupixent gets insurance coverage recognition for children and adolescents [Newsmp] Dupixent, a biologic medication that was appro... BeiGene Korea general manager Yang Ji-hye BeiGene Korea general manager Yang Ji-hye SGLT2 inhibitors occupy a third of the K-Orange Book in 2022 SGLT2 inhibitors occupy a third of the K-Orange Book in 2022 One-fifth of KOSDAQ pharmaceuticals plunged more than 50% last year One-fifth of KOSDAQ pharmaceuticals plunged more than 50% last year AstraZeneca registered highest number of patents in Korea in 2022 AstraZeneca registered highest number of patents in Korea in 2022 Cold medicine price index balloons by 13.2%, anti-inflammatory drug by 7.1% Cold medicine price index balloons by 13.2%, anti-inflammatory drug by 7.1% Five drugmakers enter the top 100 best growth in 2022 on KOSPI Five drugmakers enter the top 100 best growth in 2022 on KOSPI Benefits for AjovyㆍLucen-BSㆍAmeliebou are granted, 25% cut in Revlimid Benefits for AjovyㆍLucen-BSㆍAmeliebou are granted, 25% cut in Revlimid AjovyㆍDovprela win insurance benefits, PraluentㆍRepathaㆍK-CAB expand [Newsmp] The benefit standards for Teva-Handok’s migrai... 처음처음이전이전12345678910다음다음다음끝끝
